Short answer
Nurix Therapeutics, Inc. (NRIX) filed an 8-K current report with the SEC on April 8, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal-quarter results for period ended February 28, 2026.
Nurix Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal-quarter results for period ended February 28, 2026
- Press release furnished as Exhibit 99.1 contains Nurix’s financial results
- Investor focus: review Exhibit 99.1 for revenue, expenses, cash position, and forward outlook
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Nurix Therapeutics, Inc. 8-K filings
Get the next NRIX 8-K as it lands
Follow NRIX for push alerts, or ask the research agent what this filing means.